Read More Pharma Industry News Johnson & Johnson’s icotrokinra demonstrates superiority in plaque psoriasis trials, setting stage for market disruption New clinical trial data from Johnson & Johnson suggests that icotrokinra results could mark a major shift in… byPallavi MadhirajuMarch 9, 2025